Thank you to the more than 22,600 attendees of the AACR Annual Meeting—a record number—for a fantastic day of cutting-edge cancer science, and to the 3,317 who engaged on X/Twitter, generating over 206 million impressions so far. #AACR24

AACR feeling honored to be included as a fellow and truly inspired. A kaleidoscope of science, medicine, technology, patient advocates, trainees, industry, newcomers and legends. All the things 🩷@CarolynBertozzi Dr. Elizabeth Jaffee @PamSharmaMDPhD Johanna Joyce

Great performance by Checkpoints band at #AACR24 reception, including two rockstar Dragonfly Tx SAB Members, Dr. Patrick Hwu & @JimAllisonPhD

Lovely solar eclipse experience with 22,000 other scientists @aacr annual meeting! Everyone sharing their glasses #AACR24

"Its not the number of T-cells, but their spatial configuration that matters for tumor removal. Spatial context is my favorite thing and The SchietiLab is demonstrating so beautifully in her talk #AACR24 and she is taking brilliant her ideas all the way to the clinic!

#MusicMonday #AACR24 Edition! I had a blast playing with Society for Immunotherapy of Cancer's house band, #TheCheckPoints last night during the AACR annual meeting! Here's our version of "Sweet Home Chicago." Ferran Prat Russell Pachynski Dr. Brad Reinfeld, MD PhD Jason Luke, MD, FACP, FASCO @JimAllisonPhD @PamSharmaMDPhD @Wolchok

I knew her way back when, already amazing then, and now the recipient of the AACR Gertrude B. Eliot Award. Way to go Yadira Soto-Feliciano #RockStar faculty member Koch Institute at MIT @mit #AACR24

Whether at MIT or beyond, the KI took time out for the dramatic eclipse on Tuesday. ☀️🕶️ Special props to the Bhatia Lab's Henry Ko, whose stellar photography skills captured the pink spots in the corona caused by solar prominences and hydrogen emissions.

Go see The Poisoner! Terrific play, written by my boss Maura McCarthy Haney, with wonderful performances La MaMa E.T.C., off-off broadway!

We have entered into a clinical collaboration with Merck to evaluate DF9001, our EGFR immune engager, in combination with Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in patients with advanced solid tumors expressing EGFR. prnewswire.com/news-releases/…

NoA Day! So proud and excited to announce that Chris Burge, Chris Dulla and I have been awarded an R01 from NINDSfunding to target alternative splicing of sodium channels for pediatric epilepsy on our first submission - thanks to PhD student Haley Dame’s amazing preliminary data

The Dragonfly team is in Chicago! #ASCO24

Come check out our poster presentation (# 165b) with Dr. Carneiro Legorreta Cancer Center at Brown University on our Phase 1/1b, First-in-Human, multi-part study of DF6215, an engineered IL-2Rα-active agonist for advanced solid tumors, in the Developmental Therapeutics-Immunotherapy poster session! #ASCO24

Thanks so much to Dragonfly Tx, on behalf of @ls_cares, for dropping off donations for our annual Holiday Party for survivors of domestic violence and their families! #CommunitySupport #SupportSurvivors #GivingBack #HolidayDonation

When Bill Haney asked to turn the microphone around and film me for his new documentary on Nobel winner Phil Sharp, who was present at the creation of the biotech industry, I quickly reassured him that I’d be certain to be a massive disappointment. Haney, though, is a persistent

John Carroll Trailer is: youtube.com/watch?v=ruJdHT…

Terrific documentary for everyone in Biotech! And for all who love Phil Sharp & RNA!!

Screening of our CEO Bill Haney's new movie documentary at #JPM25, featuring the wonderful Phil Sharp Massachusetts Institute of Technology (MIT), Nobel Prize winning RNA & splicing guru, and the Biotech Revolution (with many other impressive folks). Thank you John Carroll for doing the Q&A (and being in the film!)

In an unprecedented move, research-grant reviews have been suspended indefinitely at the world’s largest public funder of biomedical research go.nature.com/4gclXG0

We are excited to share the first interim results in patients from our SKY-0515 Phase 1 clinical trial for the treatment of Huntington's disease! You can check out the release, here: prnewswire.co.uk/news-releases/…